ATR and cancer: Despite the mutational heterogeneity of Ewing sarcoma, myelodysplastic syndrome, and clear cell renal cell carcinoma, overexpression of the R-loop resolving RNAse H1 successfully restores resistance to ATR inhibition in all three cancers discussed above.